Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Claude Code dynamic workflows are now generally available on all paid plans, including Pro for the first time. The feature writes its own orchestration scripts and coordinates up to 1,000 parallel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results